Pakistan initiates 'emergency' steps to secure drug supplies after trade suspension with India
Islamabad, Apr 26 (PTI): Pakistani health authorities have initiated "emergency preparedness" measures to secure pharmaceutical supplies in response to the suspension of trade ties with India, according to a media report on Saturday.
In response to the India's decision to suspend the Indus Water Treaty following the Pahalgam attack, Islamabad on Thursday suspended all trade with New Delhi among other moves.
Geo News reported that India trade halt triggered "urgent measures to secure" pharmaceutical needs in Pakistan and health authorities have initiated "emergency preparedness" measures to secure the supplies.
The Drug Regulatory Authority of Pakistan (DRAP) has confirmed that while there has been no formal notification regarding the ban's impact on the pharmaceutical sector, contingency plans are already in place, it said.
"Following the 2019 crisis, we had started preparing for such contingencies. We are now actively looking at alternative avenues to meet our pharmaceutical needs," the report quoted a senior DRAP official as saying.
Currently, Pakistan relies on India for 30% to 40% of its pharmaceutical raw materials, including Active Pharmaceutical Ingredients (API) and various advanced therapeutic products.
With this supply chain distributed, DRAP is seeking alternative sources from China, Russia, and several European countries.
The agency aims to ensure the continuous availability of essential medical supplies, including anti-rabies vaccines, anti-snake venom, cancer therapies, monoclonal antibodies, and other critical biological products.
While DRAP's preparedness offers some reassurance, industry insiders and health experts have warned of a looming challenge if immediate action is not taken to manage the fallout of the trade suspension.
"Pakistan imports some 30%–40% of its pharmaceutical raw material from India. We also import finished products, most importantly, anti-cancer therapies, biological products, vaccines, and sera, especially anti-rabies vaccine and anti-snake venom from India," a senior official from the Ministry of National Health Services, Regulations and Coordination said, requesting anonymity.
The Ministry of Health has yet to receive an official directive clarifying the status of pharmaceutical imports, despite the government's blanket announcement suspending all trade with India.
The pharmaceutical sector fears that disruption in the supply chain could lead to critical shortages.
The situation is further complicated by the existence of a robust black market, where unregistered and unapproved medicines are smuggled into Pakistan through Afghanistan, Iran, Dubai, and even across the eastern border, the report said.
While these channels fill gaps left by legal imports, they offer no guarantee of quality or consistent supply.
A delegation of pharmaceutical industry leaders travelled to Islamabad on Thursday to appeal for an exemption from the trade ban.
"We had meetings with DRAP and Ministry of Commerce officials to discuss the suspension of trade ties. We urged them to exempt the pharmaceutical sector from the ban, as there are many life-saving products whose raw materials come exclusively from India," said Tauqeer-ul-Haq, Chairman of the Pakistan Pharmaceutical Manufacturers Association (PPMA).
The PPMA delegation also approached the Special Investment Facilitation Council (SIFC), arguing that pharmaceutical and health-related trade must be excluded from the ban to protect patients' lives.
However, some experts see the current crisis as a wake-up call for long-term investment in local production of APIs, vaccines, and biologicals.
"This crisis could be a turning point for Pakistan," said Zafar Iqbal, a senior public health expert.
Terrorists opened fire in Jammu and Kashmir's Pahalgam on Tuesday, killing 26 people, mostly tourists, in the deadliest attack in the Valley since the Pulwama strike in 2019. The Resistance Front (TRF), a proxy of the banned Pakistan-based Lashkar-e-Taiba (LeT), claimed responsibility for the attack.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Ordinance issued to increase number of Supreme Court judges from 34 to 38
New Delhi (PTI): The government has promulgated an ordinance to increase the strength of the Supreme Court from the present 34 judges to 38, including the Chief Justice of India.
The law ministry notified the ordinance on Saturday, which amended the Supreme Court (Number of Judges) Act, 1956, to increase the sanctioned strength of the top court.
So far, the sanctioned strength of the top court was 34, including the Chief Justice of India (CJI). Now, the number of judges has been increased by four, taking the sanctioned strength to 38.
The top court will now have 37 judges, other than the CJI.
With the apex court having two vacancies at present, and the ordinance coming into force immediately, the Supreme Court Collegium will now have to recommend six names for appointment as judges in the top court.
A bill will be brought in the Monsoon Session of Parliament to convert the ordinance – an executive order – into a law passed by Parliament.
The Union Cabinet had cleared a draft bill on May 5 to increase the number of apex court judges.
The strength of the Supreme Court was last increased from 30 to 33 (excluding the CJI) in 2019.
The Supreme Court (Number of Judges) Act, as originally enacted in 1956, put the maximum number of judges (excluding the CJI) at 10.
This number was increased to 13 by the Supreme Court (Number of Judges), Amendment Act, 1960, and to 17 by another amendment to the law.
The Supreme Court (Number of Judges) Amendment Act, 1986, augmented the strength of judges from 17 to 25, excluding the CJI.
A fresh amendment in 2009 further increased the strength from 25 to 30.
Article 124(3) of the Constitution lists the qualifications required to become a Supreme Court judge.
An Indian citizen who has either served as a high court judge for at least five years, or as an advocate for 10 years, or is a distinguished jurist, can be appointed to the top court.
The strength of the Supreme Court is increased based on the recommendations of the CJI, who writes to the Union law minister. After consulting the finance ministry, the Department of Justice under the law ministry moves the Cabinet with a draft bill.
